Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly
NCT02298582Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Dec 2014
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fentanyl citrate nasal spray in procedural pain, sponsored by CHU Grenoble Alpes. Primary endpoint: Safety of intranasal fentanyl as measured by the nature and frequency of adverse effects. Started Dec 2014; status: completed.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02298582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298582.